Operating Lease, Right-of-Use Asset in USD of Fulgent Genetics, Inc. from Q4 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Fulgent Genetics, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2018 to Q3 2025.
  • Fulgent Genetics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $4.95M, a 17.1% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Fulgent Genetics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $4.95M -$1.02M -17.1% 30 Sep 2025 10-Q 07 Nov 2025
Q2 2025 $4.81M -$4.38M -47.6% 30 Jun 2025 10-Q 01 Aug 2025
Q1 2025 $5.06M -$4.17M -45.2% 31 Mar 2025 10-Q 02 May 2025
Q4 2024 $5.4M -$5.44M -50.2% 31 Dec 2024 10-Q 07 Nov 2025
Q3 2024 $5.97M -$6.44M -51.9% 30 Sep 2024 10-Q 08 Nov 2024
Q2 2024 $9.19M -$4.87M -34.7% 30 Jun 2024 10-Q 02 Aug 2024
Q1 2024 $9.23M -$4M -30.3% 31 Mar 2024 10-Q 03 May 2024
Q4 2023 $10.8M -$3.95M -26.7% 31 Dec 2023 10-K 28 Feb 2025
Q3 2023 $12.4M -$3.96M -24.2% 30 Sep 2023 10-Q 03 Nov 2023
Q2 2023 $14.1M -$3.98M -22% 30 Jun 2023 10-Q 04 Aug 2023
Q1 2023 $13.2M +$6.56M +98.5% 31 Mar 2023 10-Q 05 May 2023
Q4 2022 $14.8M +$7.64M +107% 31 Dec 2022 10-K 28 Feb 2024
Q3 2022 $16.4M +$8.86M +118% 30 Sep 2022 10-Q 07 Nov 2022
Q2 2022 $18M +$15.9M +729% 30 Jun 2022 10-Q 04 Aug 2022
Q1 2022 $6.66M +$5.74M +618% 31 Mar 2022 10-Q 05 May 2022
Q4 2021 $7.14M +$6.31M +762% 31 Dec 2021 10-K 28 Feb 2023
Q3 2021 $7.5M +$4.82M +180% 30 Sep 2021 10-Q 09 Nov 2021
Q2 2021 $2.18M -$630K -22.5% 30 Jun 2021 10-Q 10 Aug 2021
Q1 2021 $928K -$1.6M -63.2% 31 Mar 2021 10-Q 07 May 2021
Q4 2020 $828K -$1.81M -68.6% 31 Dec 2020 10-K 28 Feb 2022
Q3 2020 $2.68M -$59K -2.15% 30 Sep 2020 10-Q 09 Nov 2020
Q2 2020 $2.81M +$50K +1.81% 30 Jun 2020 10-Q 05 Aug 2020
Q1 2020 $2.53M -$333K -11.7% 31 Mar 2020 10-Q 06 May 2020
Q4 2019 $2.63M -$367K -12.2% 31 Dec 2019 10-K 08 Mar 2021
Q3 2019 $2.74M 30 Sep 2019 10-Q 08 Nov 2019
Q2 2019 $2.76M 30 Jun 2019 10-Q 12 Aug 2019
Q1 2019 $2.86M 31 Mar 2019 10-Q 10 May 2019
Q4 2018 $3M 01 Jan 2019 10-K 08 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.